A researcher in a lab looking at a tablet.

Category: Research

  • ,

    Dr. Jessica Lin and Dr. Ibiayi Dagogo-Jack join ALKtALK

    Dr. Jessica Lin Attending physician, Hematology/Oncology, Massachusetts General Hospital Instructor, Medicine, Harvard Medical School Dr. Lin: I first began interested in oncology in my undergraduate years. I started out as a biochemist, but I met a mentor who was a pediatric oncologist who also worked in basic research. He really inspired me and made me…

    Read More

  • Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

    An updated review of the most current targeted therapies in NSCLC (non-small cell lung cancer) by targetable mutation. Dr. David Konig, Dr. Spasenija S. Prince, and Dr. Sacha I Rothschild did a great review on the current status of targeted therapy in NSCLC (non-small cell lung cancer).  Because of the advancement of molecular diagnostics and…

    Read More

  • ,

    Dr. Christine Lovly joins ALKtALK

    Editor’s Note: A special thanks to Marc Rosenzweig for creating and scheduling the ALKtALK programs. Alice Chou graciously committed her time to transcribe thisALKtALK with Dr. Lovly so that it would be available here for other ALK patients. Thank you so much Alice Chou for your hard work and generosity!! . . and a big…

    Read More

  • Normal ALK Function

    What function does ALK serve in a healthy human? Read on for some fascinating proposed hypotheses. We all know that a faulty ALK activation domain leads to all kinds of trouble. But what is the normal function of the ALK protein? ALK was identified in 1997 by two groups, Iwahara et. al. and Morris et…

    Read More

  • ,

    Covid-19 vaccines and lung cancer patients

    What are Covid-19 vaccines made of and how do they work? Moreover, should lung cancer patients take them? With the rise of Covid-19 infection rates and the promise of a Covid-19 vaccine, we are going to delve into the questions of “what is a vaccine?” and “should we or should we not take it”? What…

    Read More

  • ,

    Staying active as a lung cancer patient

    What can ALKies do to stay active and improve their fitness? Read on for advice for every fitness level. Recommending regular physical activity has always been part of a doctor’s advice to every healthy adult since the 1970s. At that time, a push for intermediate/high intensity exercise to increase cardiovascular training was emphasized by athletes.…

    Read More

  • ,

    Vitamin D in cancer and Covid-19

    What is Vitamin D and does it have a role in fighting lung cancer and the Covid-19 virus? Vitamin D is a fat-soluble vitamin that is naturally present in some foods (fish such as salmon, trout, or tuna) or available as a dietary supplement. Vitamin D can also be produced by our own body when…

    Read More

  • The use of traditional chemotherapy in lung cancer

    Many of us are on a tyrosine kinase inhibitor (TKI), however there are definite benefits to the use of traditional chemotherapy (chemo). In this article, we will learn a little more about this treatment option. Chemo may be recommended by your doctor in different situations:   In stages I-III only:   Before surgery (neoadjuvant chemotherapy): Neoadjuvant…

    Read More

  • ALK patients with hight PD-L1 expression and immunotherapy

    Many of our members are wondering if immunotherapy with current checkpoint inhibitors may be a good idea for them if they have been diagnosed with a high PD-L1 expression. Spoiler alert: it is a bad idea for most. Read on to find out why. Using immunotherapy with checkpoint inhibitors has invigorated the treatment and hopes…

    Read More

  • ,

    Side effects compliation & comparison

    IMPORTANT: This table is a list of various side effects members have shared.  Please remember, this is NOT a medical document.  Please use it as a guide and a starting point.  Please consult your medical team for specific advice!  Please open the PDF for the full compilation AUTHOR: Alice Chou

    Read More

  • What is Leptomeningeal Disease and how is it treated?

    A number of our members deal with leptomeningeal disease (LMD) at some point in their diagnosis. Read more on what LMD is and how it is treated. What is Leptomeningeal Disease and how is it treated? Leptomeningeal disease (LMD) occurs when cancer cells migrate from the breast, lung, or other parts of the body to…

    Read More

  • Brain Metastasis Radiation Options

    Radiation Options to Treat Brain Metastasis: Quick Review of WBR, SRS, and SFRT Nieder et. al. wrote an easy to understand paper on the management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous. The authors used data from 17 real patients to request recommendations…

    Read More